Cytometry. Part B, Clinical cytometry
Peripheral blood plasmablasts, a potential confounder in chronic lymphocytic leukemia measureable residual disease analysis.
Jessica M Hughes, Joo Y Song, Winston Y Lee, Alexey V Danilov, Matthew G Mei, Huiyan Ma, Parastou Tizro, Olga V Danilova, Lorinda A Soma
Published: 202510.1002/cyto.b.22263
Abstract
Measurable residual disease (MRD) testing for chronic lymphocytic leukemia (CLL) is often done on peripheral blood (PB) since the concordance of results with bone marrow is high and testing is less invasive. When analyzing CLL MRD data, one must be a…
Preview only. Read the full abstract at the source